The University of Queensland

ITN Study: Preserving Beta-Cell Function with Tocilizumab in New-onset Type 1 Diabetes (NIH Grant Administered by Benaroya Research Institute at Virginia Mason) (2018–2020)

Grant type:

Immune Tolerance Network - NIAID/NIH under grant number 5UM1AI109565 - administered by Benaroya Research Institute at Virginia Mason

Researchers:

• 

  Professor Ranjeny Thomas

  Arthritis Qld Chair of Rheumatology
  

  Frazer Institute

  Faculty of Medicine

Funded by:

Immune Tolerance Network - NIAID/NIH under grant number 5UM1AI109565 - administered by Benaroya Research Institute at Virginia Mason